Research Funding

Michael Brown, PhD:
NIH 1R21AI118269-01A1 (PI: Mike Brown), Genetic basis of secondary lymphoid organ protection after virus infection
(6/15/2015 – 5/31/2017).

Shu Man Fu, MD, PhD:

  • R01 AR049449 (Fu, SM), HLA-D Region in Systemic Lupus Erythematosus Pathogenesis
    (08/01/2005-03/31/2016)
  • R01 AR047988 (Fu, SM), Cellular and Genetic Basis of Systemic Lupus Erythematosus,
    (09/28/2001-07/31/2015)

Shu Man Fu, MD, PhD, and Rahul Sharma, PhD:
IL2 and IL33 as therapeutic agents for lupus nephritis.
(02/01/2015-01/31/2018)

Peter Lobo, MD:
1 R01 DK083406 (Lobo & Okusa, co-PIs), Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal Ischemia
(03/12/2010-03/11/2016)

Mark D Okusa, MD:

  • 1R01DK105133-01A1 (Okusa) Ultrasound for Non-Invasive Prevention of Acute Kidney Injury
    (09/21/2015-9/30/2020)
  • 1R01 DK085259 (Okusa) Sphingolipids in Acute Kidney Injury and Disease Progression
    (07/15/2015-06/30/2019)
  • U18EB021787-01 (MPI: Okusa) Tailoring ultrasound technology to explore mechanisms of activation of the splenic neuroimmune axis in attenuating acute organ injury. (07/1/2015-06/30/2017) (NCE)
  • 5 T32 DK072922 (Okusa) Kidney Disease and Inflammation
    (08/01/2006-07/31/2016)
  • 5 R01 DK062324 (Okusa) Leukocyte Trafficking in Acute Renal Failure
    (07/01/2002-11/03/2016)
  • Coulter Translational Research Partnership 2015 (PIs: Mark Okusa and John Hossack). Image Guided, Non-Invasive, Ultrasound for Protection from Ischemia Reperfusion Injury.
    (7/1/15-6/3016)
  • 1 R01 DK083406 (Lobo & Okusa, co-PIs). Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal Ischemia
    (03/12/2010-03/11/2016)

Rahul Sharma, PhD & Shu Man Fu, MD, PhD:
IL2 and IL33 as therapeutic agents for lupus nephritis.
(02/01/2015-01/31/2018)

Sundararaman Swaminathan, MD:
NIH 1R01DK103043-01A1 (PI: Sundararaman Swaminathan). Targeting Cellular Iron Dynamics for Protection in Kidney Injury.
(07/13/2015 – 06/30/2020)